极低碳水化合物饮食与钠-葡萄糖协同转运蛋白2抑制剂：与酮症酸中毒相关的双重风险
Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis.
作者信息
Tougaard Ninna Hahn, Faber Jens, Eldrup Ebbe
机构信息
Department of Endocrinology, Herlev Hospital, Herlev, Denmark.
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
出版信息
BMJ Case Rep. 2019 Apr 5;12(4):e227516. doi: 10.1136/bcr-2018-227516.
Abstract
Diabetic euglycaemic ketoacidosis is a possible adverse effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i). We report a case in which the combination of SGLT2i and a strict very low-carbohydrate diet led to severe diabetic ketoacidosis in a young Caucasian man with type 2 diabetes.
摘要
糖尿病正常血糖性酮症酸中毒是钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）的一种可能的不良反应。我们报告了一例2型糖尿病的年轻白种男性病例，其SGLT2i与严格的极低碳水化合物饮食相结合导致了严重的糖尿病酮症酸中毒。
相似文献
1
Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis.极低碳水化合物饮食与钠-葡萄糖协同转运蛋白2抑制剂：与酮症酸中毒相关的双重风险
BMJ Case Rep. 2019 Apr 5;12(4):e227516. doi: 10.1136/bcr-2018-227516.
2
[Life-threatening ketoacidosis in patients with type 2 diabetes on LCHF diet].采用低碳水化合物高脂肪饮食的2型糖尿病患者出现危及生命的酮症酸中毒
Lakartidningen. 2018 Jun 29;115:E4AD.
3
Sodium-glucose co-transporter 2 inhibitors in the peri-operative period: A warning to all clinicians.围手术期钠-葡萄糖协同转运蛋白2抑制剂：给所有临床医生的警示
BJU Int. 2019 May;123 Suppl 5:6-7. doi: 10.1111/bju.14766.
4
[Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report].[服用恩格列净时因低碳水化合物饮食导致正常血糖性糖尿病酮症酸中毒的风险：一例报告]
Yakugaku Zasshi. 2019;139(11):1479-1483. doi: 10.1248/yakushi.19-00120.
5
Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.一名17岁2型糖尿病青年中糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂使用之间的可能关联
CMAJ. 2021 Sep 7;193(35):E1385-E1388. doi: 10.1503/cmaj.202627.
6
[Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases].[2型糖尿病患者使用SGLT2抑制剂治疗后出现的糖尿病正常血糖性酮症或酮症酸中毒：比利时系列临床病例]
Rev Med Interne. 2020 Apr;41(4):226-231. doi: 10.1016/j.revmed.2019.12.006. Epub 2019 Dec 19.
7
Low carbohydrate diet while taking dapagliflozin: A case report and review of literature.服用达格列净时的低碳水化合物饮食：一例病例报告及文献综述
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):361-363. doi: 10.1016/j.dsx.2021.01.016. Epub 2021 Jan 23.
8
SGLT-2 inhibitor associated euglycaemic diabetic ketoacidosis in an orthopaedic trauma patient.骨科创伤患者中 SGLT-2 抑制剂相关的血糖正常性糖尿病酮症酸中毒。
BMJ Case Rep. 2022 Sep 16;15(9):e250233. doi: 10.1136/bcr-2022-250233.
9
Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment.血糖正常的糖尿病酮症酸中毒作为 SGLT-2 抑制剂的并发症：流行病学、病理生理学和治疗。
Expert Opin Drug Saf. 2020 Jun;19(6):673-682. doi: 10.1080/14740338.2020.1764532. Epub 2020 Jun 10.
10
Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.日本2型糖尿病患者中钠-葡萄糖协同转运蛋白2抑制剂的使用与膳食碳水化合物摄入量：一项随机、开放标签、三臂平行对照的探索性研究。
Diabetes Obes Metab. 2017 May;19(5):739-743. doi: 10.1111/dom.12848. Epub 2017 Feb 21.
引用本文的文献
1
Nutritional assessment and medical dietary therapy for management of obesity in patients with non-dialysis chronic kidney disease: a practical guide for endocrinologist, nutritionists and nephrologists. A consensus statement from the Italian society of endocrinology (SIE), working group of the club nutrition-hormones and metabolism; the Italian society of nutraceuticals (SINut), club ketodiets and nutraceuticals "KetoNut-SINut"; and the Italian society of nephrology (SIN).非透析慢性肾脏病患者肥胖的营养评估和医学膳食治疗：内分泌学家、营养师和肾脏病学家实用指南。意大利内分泌学会（SIE）、俱乐部营养-激素和代谢工作组；意大利营养保健品学会（SINut）、酮饮食和营养保健品“KetoNut-SINut”俱乐部；以及意大利肾脏病学会（SIN）的共识声明。
J Endocrinol Invest. 2024 Dec;47(12):2889-2913. doi: 10.1007/s40618-024-02446-8. Epub 2024 Sep 18.
2
Evidence-based European recommendations for the dietary management of diabetes.欧洲基于证据的糖尿病饮食管理建议。
Diabetologia. 2023 Jun;66(6):965-985. doi: 10.1007/s00125-023-05894-8.
3
Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver.关于生酮饮食和间歇性禁食对非酒精性脂肪肝患者影响的当前证据
J Clin Transl Hepatol. 2022 Aug 28;10(4):730-739. doi: 10.14218/JCTH.2021.00494. Epub 2022 May 6.
4
An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.一例伴有波折的隐匿性正常血糖性糖尿病酮症酸中毒病例。
Cureus. 2022 Apr 10;14(4):e24016. doi: 10.7759/cureus.24016. eCollection 2022 Apr.
5
Diets for weight management in adults with type 2 diabetes: an umbrella review of published meta-analyses and systematic review of trials of diets for diabetes remission.成人 2 型糖尿病患者体重管理的饮食方案：已发表荟萃分析的伞状评价和糖尿病缓解饮食试验的系统评价
Diabetologia. 2022 Jan;65(1):14-36. doi: 10.1007/s00125-021-05577-2. Epub 2021 Nov 17.
6
Strawberry pink blood: hypertriglyceridaemia and diabetic ketoacidosis secondary to poorly controlled type 2 diabetes mellitus.草莓红色血：继发于控制不佳的 2 型糖尿病的高甘油三酯血症和糖尿病酮症酸中毒。
BMJ Case Rep. 2021 Aug 20;14(8):e243696. doi: 10.1136/bcr-2021-243696.
7
A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed.1例使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂并采用生酮饮食的患者发生糖尿病酮症酸中毒：一个不容错过的关键三联征。
Case Rep Endocrinol. 2020 Aug 13;2020:8832833. doi: 10.1155/2020/8832833. eCollection 2020.
8
Scientific evidence underlying contraindications to the ketogenic diet: An update. ketogenic 饮食禁忌的科学依据：更新。
Obes Rev. 2020 Oct;21(10):e13053. doi: 10.1111/obr.13053. Epub 2020 Jul 10.
9
Euglycemic Diabetic Ketoacidosis in Concurrent Very Low-carbohydrate Diet and Sodium-glucose Transporter-2 Inhibitor Use: A Case Report.同时采用极低碳水化合物饮食和使用钠-葡萄糖协同转运蛋白2抑制剂时出现的正常血糖性糖尿病酮症酸中毒：一例报告
Clin Pract Cases Emerg Med. 2020 Apr 23;4(2):185-188. doi: 10.5811/cpcem.2020.2.45904. eCollection 2020 May.
10
Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes.糖尿病患者的低碳水化合物和极低碳水化合物饮食
Diabetes Spectr. 2020 May;33(2):133-142. doi: 10.2337/ds19-0070.
本文引用的文献
1
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial.度拉鲁肽与 SGLT2 抑制剂联用治疗血糖控制不佳的 2 型糖尿病患者（AWARD-10）：一项 24 周、随机、双盲、安慰剂对照试验。
Lancet Diabetes Endocrinol. 2018 May;6(5):370-381. doi: 10.1016/S2213-8587(18)30023-8. Epub 2018 Feb 23.
2
The Role of Sodium-Glucose Cotransporter 2 Inhibitors in the Management of Type 2 Diabetes.钠-葡萄糖共转运蛋白 2 抑制剂在 2 型糖尿病管理中的作用。
Can J Diabetes. 2017 Oct;41(5):517-523. doi: 10.1016/j.jcjd.2017.08.241.
3
Sodium-glucose co-transporter-2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open-label, 3-arm parallel comparative, exploratory study.日本2型糖尿病患者中钠-葡萄糖协同转运蛋白2抑制剂的使用与膳食碳水化合物摄入量：一项随机、开放标签、三臂平行对照的探索性研究。
Diabetes Obes Metab. 2017 May;19(5):739-743. doi: 10.1111/dom.12848. Epub 2017 Feb 21.
4
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.每周一次艾塞那肽加每日一次达格列净对比二甲双胍单药治疗控制不佳的 2 型糖尿病患者中单独使用艾塞那肽或达格列净（DURATION-8）：一项 28 周、多中心、双盲、3 期、随机对照试验。
Lancet Diabetes Endocrinol. 2016 Dec;4(12):1004-1016. doi: 10.1016/S2213-8587(16)30267-4. Epub 2016 Sep 16.
5
Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet.一名低碳水化合物饮食的糖尿病患者使用钠-葡萄糖协同转运蛋白2抑制剂后发生酮症酸中毒的病例。
J Diabetes Investig. 2015 Sep;6(5):587-90. doi: 10.1111/jdi.12330. Epub 2015 Feb 20.
6
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors.正常血糖性糖尿病酮症酸中毒：SGLT2抑制剂相关的可预测、可检测且可预防的安全问题
Diabetes Care. 2015 Sep;38(9):1638-42. doi: 10.2337/dc15-1380.
7
Acute intractable vomiting and severe ketoacidosis secondary to the Dukan Diet©.杜坎饮食法导致的急性顽固性呕吐和严重酮症酸中毒。
J Emerg Med. 2014 Oct;47(4):e109-12. doi: 10.1016/j.jemermed.2014.06.020. Epub 2014 Aug 22.
8
Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2.达格列净，一种选择性钠-葡萄糖共转运蛋白 2 抑制剂的临床药代动力学和药效学。
Clin Pharmacokinet. 2014 Jan;53(1):17-27. doi: 10.1007/s40262-013-0104-3.
9
A life-threatening complication of Atkins diet.阿特金斯饮食法的一种危及生命的并发症。
Lancet. 2006 Mar 18;367(9514):958. doi: 10.1016/S0140-6736(06)68394-3.
10
Ketoacidosis during a low-carbohydrate diet.低碳水化合物饮食期间的酮症酸中毒。
N Engl J Med. 2006 Jan 5;354(1):97-8. doi: 10.1056/NEJMc052709.
Zotero 插件